EAG Laboratories

Executive Summary

EAG Laboratories is a France-based contract research organization (CRO) with over 45 years of experience providing specialized analytical testing and consulting services to the pharmaceutical industry. Its core expertise lies in extractables and leachables (E&L) studies, contaminant identification, and complex material characterization, supporting clients across product development, regulatory compliance, and manufacturing troubleshooting. As a private company, EAG is well-positioned to benefit from increasing regulatory demands for container-closure system testing and impurity profiling, particularly in the injectable and biologic segments. The company's long-standing reputation and multidisciplinary science base offer a stable revenue stream, though growth is largely tied to client project volumes rather than internal pipeline catalysts. With no disclosed funding rounds or valuation, the company remains a niche player in the analytical CRO market, serving both large pharma and generic drug manufacturers.

Upcoming Catalysts (preview)

• Q3 2026New FDA/EMA Guidance on Extractables and Leachables75% success
• TBDExpansion into Biologics Characterization Services60% success
• Q3 2026Strategic Partnership with a Top-20 Pharmaceutical Company40% success